TherapeuticsMD (TXMD) Operating Expenses (2010 - 2026)

TherapeuticsMD has reported Operating Expenses for 17 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 13.56% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $7.2 million (down 6.65% YoY), and the FY2025 full-year result was $7.4 million, down 5.86% from the prior year.
• Operating Expenses for Q1 2026 stood at $1.4 million, down from $2.4 million in the prior quarter.
• The five-year high for Operating Expenses was $20.1 million in Q4 2022, with the low at $1.3 million in Q4 2024.
• Historically, Operating Expenses has averaged $5.5 million across 5 years, with a median of $2.1 million in 2023.
• Annual changes were most pronounced in 2022 — Operating Expenses surged 125.87% — and 2023, when it tumbled 89.5%.
• TherapeuticsMD's Operating Expenses stood at $20.1 million in 2022, then plunged by 89.5% to $2.1 million in 2023, then plunged by 37.58% to $1.3 million in 2024, then surged by 85.37% to $2.4 million in 2025, then sank by 40.82% to $1.4 million in 2026.
• The last three Operating Expenses figures came in at $1.4 million (Q1 2026), $2.4 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.